Venture Catalysts fully exits TruNativ, notching 12.73x return and 67% IRR on wellness D2C bet
Venture Catalysts has taken a complete exit from Indian nutrition and wellness D2C brand TruNativ, realizing 12.73x (67% IRR) on its June 2021 seed round and 1.34x (18% IRR) on a September 2024 follow-on. TruNativ expanded its portfolio and grew across digital and retail channels.
What happened
Venture Catalysts fully exited Indian nutrition and wellness D2C brand TruNativ, realizing 12.73x and 1.34x returns across two rounds. TruNativ has expanded its
Key facts
- 12.73x return
- 67% IRR
- 1.34x return
- 18% IRR
- June 2021 first investment
- September 2024 follow-on
- June 2026 exit
Why this matters
A fully exited, multi-channel nutrition brand with a proven growth track record is now uncontested by its lead investor, signaling a potential consolidation or acquisition window in Indian wellness D2C.
What to watch
- New seed rounds announced in nutrition/wellness D2C within 2 quarters
- TruNativ revenue/retail-doorcount disclosures post-exit
- Acquirer M&A activity in adjacent wellness brands
- Rising ad-spend/CAC benchmarks reported by category players
- Map who acquired the VC stake and their consolidation intent
- Screen comparable Indian wellness/nutrition D2C brands at seed stage for entry timing
- Model CAC and retail-margin trajectory as category attracts copycats
- Track VC's redeployment of exit proceeds for thesis signal